Roles of microRNA-34a in the pathogenesis of placenta accreta

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 1, 2013, Pages 67-74

  Umemura, Kota ^a   Ishioka, Shin Ichi ^a   Endo, Toshiaki ^a   Ezaka, Yoshiaki ^a   Takahashi, Madoka ^a   Saito, Tsuyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Fluorescent in situ hybridization; MicroRNA 34a; Placenta accreta; Plasminogen activator inhibitor 1

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA 34A; MORPHOLINO OLIGONUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANTISENSE THERAPY; ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CYTOPLASM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PATHOGENESIS; PLACENTA ACCRETA; PROTEIN EXPRESSION;

CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MICRORNAS; PLACENTA; PLACENTA ACCRETA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; TROPHOBLASTS;

EID: 84875062330     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.01898.x     Document Type: Article

References (33)

1. Allahdin S, Voigt S, Htwe TT. Management of placenta praevia and accreta. J Obstet Gynaecol 2011; 31: 1-6.
2. Comstock CH. The antenatal diagnosis of placental attachment disorders. Curr Opin Obstet Gynecol 2011; 23: 117-122.
3. Endo T, Hayashi T, Shimizu A et al. Successful uteruspreserving surgery for treatment of chemotherapy-resistant placenta increta. Gynecol Obstet Invest 2010; 69: 112-115.
4. Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA, Mercer B, Berghella V et al. Placenta accreta. Am J Obstet Gynecol 2010; 203: 430-439.
5. Bartel D. Micro RNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Takizawa T, Gemma A, Ui-Tei K et al. Basic and clinical studies on functional RNA molecules for advanced medical technologies. J Nippon Med Sch 2010; 77: 71-79.
7. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011; 223: 102-115.
8. Ying SY, Chang DC, Lin SL. The microRNA (miRNA): Overview of the RNA genes that modulate gene function. Mol Biotechnol 2008; 38: 257-268.
9. Li B, Hu Y, Ye F, Li Y, Lv W, Xie X. Reduced miR-34a expression in normal cervical tissues and cervical lesions with highrisk human papillomavirus infection. Int J Gynecol Cancer 2010; 20: 597-604.
10. Lodygin D, Tarasov V, Epanchintsev A et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008; 7: 2591-2600.
11. Lee JH, Voortman J, Dingemans AM et al. MicroRNA expression and clinical outcome of small cell lung cancer. PLoS ONE 2011; 6: e21300. Epub.
12. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T. Cytokine production in chorioamnionitis. J Reprod Immunol 2000; 45: 186-195.
13. Pang RT, Leung CO, Ye TM et al. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010; 31: 1037-1044.
14. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
15. Bray SJ. Notch signaling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678-689.
16. Sarikaya DP, Jerome-Majewska LA. Notch1 and the activated NOTCH1 intracellular domain are expressed in differentiated trophoblast cells. Cell Biol Int 2011; 35: 443-447.
17. Raver-Shapira N, Marciano E, Meiri E et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
18. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 1996; 383: 441-443.
19. Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC, Lawrence DA. Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J Biol Chem 2001; 276: 8135-8141.
20. Ullsse S, Baldini E, Sorrenti S, D'Armiento M. The urokinase activator system:A target for anti-cancer therapy. Curr Cancer Drug Targets 2009; 9: 32-71.
21. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21: 1104-1117.
22. McMahon GA, Petitclerc E, Stefansson S et al. Plasminogen activator Inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 2001; 276: 33964-33968.
23. Feng Q, Liu Y, Liu K et al. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Placenta 2000; 21: 184-193.
24. Gabriely G, Wurdlinger T, Kesari S et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulator. Mol Cell Biol 2008; 28: 5369-5380.
25. Sun L, YanW, Sun G et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 2011; 1389: 9-18.
26. Jovanovic M, Vicovac L. Interleukin-6 stimulates cell migration, invasion and integrin expression in HTR-8/SVneo cell line. Placenta 2009; 30: 320-328.
27. Jovanovic M, Stefanoska I, Radojcic L, Vicovac L. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta. Reproduction 2010; 139: 789-798.
28. Hu Y, Dutz JP, MacCaiman CD, Yong P, Tan R, von Dadelszen P. Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: A role for IFNgamma. J Immunol 2006; 177: 8522-8530.
29. Sekizawa A, Jimbo M, Saito H et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002; 48: 353-354.
30. Hahn S, Rusterholz C, Hösli I, Lapaire O. Cell-free nucleic acids as potential markers for preeclampsia. Placenta 2011; 32 (Suppl): S17-S20.
31. Cermeli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-Alcoholic fatty liver disease. PLoS ONE 2011; 6: e23937.
32. Kong L, Zhu J, HanWet al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetol 2011; 48: 61-69.
33. Mazouni C, Gorincour G, Juhan V, Bretelle F. Placenta accreta: A review of current advances in prenatal diagnosis. Placenta 2007; 28: 599-603.